CANT1 as a novel prognostic biomarker in triple‑negative breast cancer
Oncology Letters · 09.03.2026 · 31 (5) · 1-11
DOI: 10.3892/ol.2026.15519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 09.03.2026. Verfasst von Doğan Bayram und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Ankara City Hospital, Ankara 06800, Turkey. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Ankara City Hospital, Ankara 06800, Turkey.
- Department of Pathology, Ankara City Hospital, Ankara 06800, Turkey.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Gazi University, Ankara 06330, Turkey.
- Department of Medical Oncology, Afyonkarahisar State Hospital, Afyonkarahisar 03110, Turkey.
Zitieren
APA
Bayram, D., Çolak, A., Karabulut, Ş., Özsan Çelebi, S. N., Hafizoğlu, E., Türkay, D. Ö., Bal, Ö., Algin, E., Yücel, Ş., Şendur, M. A. N., Civelek, B., & Uçar, G. (2026). CANT1 as a novel prognostic biomarker in triple‑negative breast cancer. Oncology Letters, 31(5), 1-11. https://doi.org/10.3892/ol.2026.15519
Vancouver
Bayram D, Çolak A, Karabulut Ş, Özsan Çelebi SN, Hafizoğlu E, Türkay DÖ, et al. CANT1 as a novel prognostic biomarker in triple‑negative breast cancer. Oncology Letters. 2026;31(5):1-11. doi:10.3892/ol.2026.15519
BibTeX
@article{Bayram2026,
author = {Bayram, Doğan and Çolak, Aysel and Karabulut, Şefika and Özsan Çelebi, Sema Nur and Hafizoğlu, Emre and Türkay, Duriye Özer and Bal, Öznur and Algin, Efnan and Yücel, Şebnem and Şendur, Mehmet Ali Nahit and Civelek, Burak and Uçar, Gökhan},
title = {CANT1 as a novel prognostic biomarker in triple‑negative breast cancer},
journal = {Oncology Letters},
year = {2026},
volume = {31},
number = {5},
pages = {1--11},
doi = {10.3892/ol.2026.15519}
}
EUVIMED